Prentiss Christopher B

Insider CIK 1717583 · ADMS Chief Financial Officer · MNKD Chief Financial Officer

Track record PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

Track record

See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.

Upgrade to Pro · $99/year Already Pro? Log in

Trades across companies

Ticker	Code	Trade	Filed	Shares	Price	Value	Owned after
MNKD MANNKIND CORP	F Tax w/h	2026-07-15	2026-07-17	10,675	$4.09	$43.7K	318,668	SEC↗
MNKD MANNKIND CORP	F Tax w/h	2026-07-15	2026-07-17	11,572	$4.09	$47.3K	329,343	SEC↗
MNKD MANNKIND CORP	F Tax w/h	2026-04-22	2026-04-24	12,267	$2.74	$33.6K	338,924	SEC↗
MNKD MANNKIND CORP	A Award deriv	2026-03-23	2026-03-25	221,000	—	$0	221,000	SEC↗
MNKD MANNKIND CORP	A Award deriv	2026-03-23	2026-03-25	217,000	—	$0	217,000	SEC↗
MNKD MANNKIND CORP	A Award	2026-03-01	2026-03-03	5,000	$3.27	$16.4K	348,854	SEC↗
MNKD MANNKIND CORP	F Tax w/h	2025-07-15	2025-07-17	11,540	$3.85	$44.4K	343,854	SEC↗
MNKD MANNKIND CORP	A Award deriv	2025-05-13	2025-05-15	145,000	—	$0	145,000	SEC↗
MNKD MANNKIND CORP	A Award	2025-05-13	2025-05-15	119,000	—	$0	353,193	SEC↗
MNKD MANNKIND CORP	A Award	2024-05-15	2025-03-28	103,600	—	$0	103,600	SEC↗
MNKD MANNKIND CORP	A Award deriv	2024-05-15	2024-05-17	158,000	—	$0	158,000	SEC↗
MNKD MANNKIND CORP	A Award	2024-05-15	2024-05-17	103,600	—	$0	103,600	SEC↗
MNKD MANNKIND CORP	A Award	2024-05-15	2024-05-17	129,000	—	$0	232,600	SEC↗
ADMS Adamas Pharmaceuticals Inc	D To issuer deriv	2021-11-24	2021-11-24	37,500	—	$0	0	SEC↗
ADMS Adamas Pharmaceuticals Inc	D To issuer deriv	2021-11-24	2021-11-24	50,000	—	$0	0	SEC↗
ADMS Adamas Pharmaceuticals Inc	A Award	2021-11-24	2021-11-24	18,750	—	$0	163,767	SEC↗
ADMS Adamas Pharmaceuticals Inc	U Tender	2021-11-24	2021-11-24	163,767	—	$0	0	SEC↗
ADMS Adamas Pharmaceuticals Inc	S Sale	2021-03-22	2021-03-23	2,422	$5.48	$13.3K	145,017	SEC↗
ADMS Adamas Pharmaceuticals Inc	A Award	2021-03-02	2021-03-03	75,000	—	$0	147,439	SEC↗
ADMS Adamas Pharmaceuticals Inc	S Sale	2021-02-01	2021-02-01	3,821	$6.36	$24.3K	72,439	SEC↗
ADMS Adamas Pharmaceuticals Inc	S Sale	2021-01-20	2021-01-22	2,630	$4.41	$11.6K	76,260	SEC↗
ADMS Adamas Pharmaceuticals Inc	S Sale	2020-11-02	2020-11-02	2,050	$3.21	$6.6K	78,890	SEC↗
ADMS Adamas Pharmaceuticals Inc	A Award	2020-03-17	2020-03-19	10,000	—	$0	80,940	SEC↗
ADMS Adamas Pharmaceuticals Inc	S Sale	2020-01-21	2020-01-23	1,269	$5.92	$7.5K	70,940	SEC↗
ADMS Adamas Pharmaceuticals Inc	A Award deriv	2019-11-07	2019-11-08	50,000	—	$0	50,000	SEC↗
ADMS Adamas Pharmaceuticals Inc	A Award	2019-11-07	2019-11-08	25,000	—	$0	72,209	SEC↗
ADMS Adamas Pharmaceuticals Inc	S Sale	2019-07-22	2019-07-23	1,082	$6.00	$6.5K	47,209	SEC↗
ADMS Adamas Pharmaceuticals Inc	A Award deriv	2019-04-08	2019-04-10	37,500	—	$0	37,500	SEC↗
ADMS Adamas Pharmaceuticals Inc	A Award	2019-04-08	2019-04-10	18,750	—	$0	48,291	SEC↗
ADMS Adamas Pharmaceuticals Inc	S Sale	2019-03-20	2019-03-21	1,185	$8.00	$9.5K	29,541	SEC↗
ADMS Adamas Pharmaceuticals Inc	A Award	2018-12-27	2018-12-28	12,500	—	$0	30,726	SEC↗
ADMS Adamas Pharmaceuticals Inc	S Sale	2018-12-20	2018-12-26	228	$7.51	$1.7K	18,226	SEC↗
ADMS Adamas Pharmaceuticals Inc	S Sale	2018-03-21	2018-03-22	567	$25.98	$14.7K	17,758	SEC↗
ADMS Adamas Pharmaceuticals Inc	A Award deriv	2018-03-06	2018-03-09	30,000	—	$0	30,000	SEC↗
ADMS Adamas Pharmaceuticals Inc	A Award	2018-03-06	2018-03-09	5,000	—	$0	18,325	SEC↗
ADMS Adamas Pharmaceuticals Inc	A Award deriv	2017-10-06	2017-10-10	15,000	—	$0	15,000	SEC↗
ADMS Adamas Pharmaceuticals Inc	A Award	2017-10-06	2017-10-10	2,500	—	$0	12,405	SEC↗